Literature DB >> 12535246

In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.

Jérôme Mezui Me Ndong1, Christiane Atteke, Agnès Aubouy, Mohamed Bakary, Jacques Lébibi, Philippe Deloron.   

Abstract

OBJECTIVES: To determine the in vitro activity of antimalarial drugs against isolates of Plasmodium falciparum in Gabon.
METHODS: Plasmodium falciparum isolates were collected from symptomatic infections in the hospitals of Bakoumba and Franceville, south-east Gabon and in 2000. In vitro activity of chloroquine, quinine, mefloquine, halofantrine was measured by the isotopic microtest.
RESULTS: A total of 60 and 62 isolates gave interpretable data in Franceville and Bakoumba, respectively. In Franceville, 50.0% (mean IC50 = 111.7 nm), 0% (mean IC50 = 156.7 nm), and 21.2% (mean IC50 = 12.4 nm) of isolates, respectively, showed in vitro resistance to chloroquine, quinine and mefloquine. In Bakoumba, we saw resistance to chloroquine, quinine, mefloquine and halofantrine in 95.0% (mean IC50 = 325.8 nm), 10.2% (mean IC50 = 385.5 nm), 47.5% (mean IC50 = 24.5 nm) and 18.2% (mean IC50 = 1.9 nm) of isolates, respectively. Activities of chloroquine and mefloquine, chloroquine and quinine, and mefloquine and quinine were positively correlated.
CONCLUSIONS: Antimalarial drug resistance is high in this area of Gabon. The extent of resistance is disparate, as all tested drugs were less efficacious in Bakoumba than in Franceville.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535246     DOI: 10.1046/j.1365-3156.2003.00967.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

1.  In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.

Authors:  John Okombo; Steven M Kiara; Josea Rono; Leah Mwai; Lewa Pole; Eric Ohuma; Steffen Borrmann; Lynette Isabella Ochola; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

2.  In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.

Authors:  Rafika Zatra; Jean Bernard Lekana-douki; Faustin Lekoulou; Ulrick Bisvigou; Edgard Brice Ngoungou; Fousseyni S Toure Ndouo
Journal:  BMC Infect Dis       Date:  2012-11-15       Impact factor: 3.090

3.  Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.

Authors:  Adoke Yeka; James Tibenderana; Jane Achan; Umberto D'Alessandro; Ambrose O Talisuna
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

4.  Trafficked Proteins-Druggable in Plasmodium falciparum?

Authors:  Jasmin Lindner; Kamila Anna Meissner; Isolmar Schettert; Carsten Wrenger
Journal:  Int J Cell Biol       Date:  2013-04-28

5.  Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model.

Authors:  Nicanor Obaldía; Geoffrey S Dow; Lucia Gerena; Dennis Kyle; William Otero; Pierre-Yves Mantel; Nicholas Baro; Rachel Daniels; Angana Mukherjee; Lauren M Childs; Caroline Buckee; Manoj T Duraisingh; Sarah K Volkman; Dyann F Wirth; Matthias Marti
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

6.  Differential Prevalences of Pfmdr1 Polymorphisms in Symptomatic and Asymptomatic Plasmodium falciparum Infections in Lastoursville: A Rural Area in East-Central Gabon.

Authors:  Steede Seinnat Ontoua; Lady Charlene Kouna; Sandrine Lydie Oyegue-Liabagui; Dominique Fatima Voumbo-Matoumona; Diamella Nancy Moukodoum; Romeo Karl Imboumy-Limoukou; Jean Bernard Lekana-Douki
Journal:  Infect Drug Resist       Date:  2021-07-24       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.